Related Experiment Video
Updated: Jun 27, 2026
08:55
Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence
Published on: November 2, 2014
Delayed malignant melanoma recurrence simulating primary ovarian cancer: case report
Anastasios Boutis1, Rosalia Valeri, Ippokratis Korantzis
13rd Department of Clinical Oncology, Theagenion Cancer Hospital, Thessaloniki, Greece. tboutis@otenet.gr
World Journal of Surgical Oncology
|November 22, 2008
Summary
Metastatic ovarian melanoma is rare and difficult to diagnose. Ascitic fluid cytology accurately diagnosed a case, preventing unnecessary surgery and guiding palliative care.
Area of Science:
- Oncology
- Gynecologic Oncology
- Dermatology
Background:
- Metastatic involvement of the ovary from malignant melanoma is uncommon.
- It often presents as disseminated disease with a poor prognosis.
- Delayed ovarian recurrences can mimic primary ovarian cancer.
Observation:
- A premenopausal patient with malignant melanoma experienced late abdominal and ovarian metastasis.
- Ascitic fluid cytology was utilized for diagnosis.
- This led to accurate preoperative diagnosis.
Findings:
- Ascitic fluid cytology enabled accurate preoperative diagnosis of ovarian metastasis from malignant melanoma.
- This diagnosis helped avoid unnecessary surgical procedures.
- The patient received appropriate palliative care.
Implications:
- Accurate diagnosis of secondary ovarian melanoma is crucial to avoid overtreatment.
- Non-invasive diagnostic methods like cytology are vital.
- Palliative care and selective surgical intervention are key for managing this condition.
